Michelle A Collins

US Patent:

7943367, May 17, 2011

Filed:

Sep 19, 2007

Appl. No.:

11/857525

Inventors:

Michelle Collins - Oakland CA, US
Steven Kulisch - Pleasant Hill CA, US
Charles W. Ragsdale - Concord CA, US
Teresa Rubio - El Cerrito CA, US
Gary Bouchard - Santa Cruz CA, US

Assignee:

Bio-Rad Laboratories, Inc. - Hercules CA

International Classification:

C12M 1/42
C12M 3/00

US Classification:

4352852

Abstract:

A chamber that includes electrical contacts and a protective lid with a manually operated release is designed to receive a multi-well electroporation plate and to allow high-throughput electroporation on the well contents with minimal risk of electrical shock to the user and minimal opportunity for sample loss and contamination.

US Patent:

20140288014, Sep 25, 2014

Filed:

Mar 18, 2014

Appl. No.:

14/218153

Inventors:

- Hayward CA, US
Andrew Thompson - Oakland CA, US
Michelle L. Collins - Oakland CA, US
Jeffrey Gerard Hippler - South Charleston WV, US
James Astwood - Alameda CA, US

International Classification:

A61K 31/202
A61K 31/7032

US Classification:

514 25, 514560

Abstract:

The present invention provides compositions for a crude algal oil and methods of making thereof. The compositions can be used to produce a highly pure omega-3 eicosapentaenoic acid (EPA) formulation.

US Patent:

20140271706, Sep 18, 2014

Filed:

Sep 12, 2013

Appl. No.:

14/025772

Inventors:

James Astwood - Alameda CA, US
Michelle L. Collins - Oakland CA, US
Brian Connolly - Hayward CA, US

Assignee:

Aurora Algae, Inc. - Hayward CA

International Classification:

A23L 1/30
A61K 31/202
A61K 31/232
A61K 31/661
A61K 31/7028
A61K 36/02
A61K 31/201

US Classification:

42419517, 426601, 426590, 426648, 426655

Abstract:

Provided herein are exemplary compositions, products, and capsules utilizing POA, EPA, blends of POA and EPA, total algal oil compositions, and/or whole biomass compositions in methods of inhibiting inflammation including in cardiovascular disease, diabetes, obesity, stroke, metabolic syndromes, dementia, Alzheimer's disease, and/or cancer. The exemplary compositions, products, and capsules may be orally, topically, intravenously, and/or subcutaneously administered. The exemplary compositions herein may be used as feed, food, food supplements, beverages, beverage supplements, nutritional products, products for athletic performance, pharmaceutical products, and/or medical products for mammalian use, including humans.

US Patent:

20140274922, Sep 18, 2014

Filed:

Sep 12, 2013

Appl. No.:

14/025766

Inventors:

Leslie van der Meulen - Lafayette CA, US
Daniel Fleischer - Oakland CA, US
Michelle L. Collins - Oakland CA, US
James Astwood - Alameda CA, US
Jeffrey Gerard Hippler - South Charleston WV, US
Andrew Thompson - Oakland CA, US

Assignee:

Aurora Algae, Inc. - Hayward CA

International Classification:

A61K 31/201
A61K 31/683
A61K 31/7012
A61K 31/202
A61K 31/231

US Classification:

514 25, 514560, 514549, 514121

Abstract:

Provided herein are exemplary algal omega 7 compositions, including algal fatty acid compositions comprising by dry weight from about approximately 0.5% to about approximately 99% C16:1 n7 palmitoleic acid (POA). Such algal compositions may also include (either individually or any combination of) by dry weight: from about approximately 0% to about approximately 20% saturated fatty acids; from about approximately 0% to about approximately 99% arachidonic acid; from about approximately 0% to about 99% docosahexaenoic acid; and/or from about approximately 0% to about approximately 99% eicosapentaenoic acid. Further exemplary algal fatty acid compositions may include by dry weight about approximately 90% POA, less than about approximately 20% saturated fatty acids, less than about approximately 10% ARA, substantially no DHA, and less than about approximately 10% EPA.

US Patent:

20140275596, Sep 18, 2014

Filed:

Sep 12, 2013

Appl. No.:

14/025756

Inventors:

James Astwood - Alameda CA, US
Leslie van der Meulen - Lafayette CA, US
Michelle Collins - Oakland CA, US
Jeffrey Gerard Hippler - South Charleston WV, US

Assignee:

Aurora Algae, Inc. - Hayward CA

International Classification:

C11B 3/00

US Classification:

554224

Abstract:

Provided herein are exemplary algal fatty acid compositions comprising by dry weight approximately 0.5% to approximately 99% C20:5 n3 Eicosapentaenoic acid (EPA) and approximately 0.5% to approximately 99% C16:1 n7 palmitoleic acid (POA). Further exemplary algal fatty acid compositions may comprise (in addition to the above) one or more of the following by dry weight: between approximately 0% and 99% arachidonic acid; between approximately 0% and 99% docosahexaenoic acid; and/or less than approximately 10% saturated fatty acids (including 0% saturated fatty acids or substantially saturated fatty acid free). Further exemplary saturated fatty acyl moiety-rich algal compositions may be in a form of an ethyl ester (EE), a mono, di- or triacylglycerol (MAG, DAG, TAG), a phospholipid (PL), a galactolipid (GL), free fatty Acid (FFA), or a sulfoquinovosyl diacylglycerol (SQDG).